Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine the overall response rate (complete
response + partial response) to a combination of bavituximab plus carboplatin and paclitaxel
in patients with previously untreated locally advanced or metastatic non-small cell lung
cancer.